{"date":"2026-09-17","count":11,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6547-2026-09-17-1753-wf2p0v","company_id":"6547","company":"高端疫苗","market":"上櫃","industry":"生技醫療","date":"2026-09-17","time":"17:53:09","subject":"公告高端疫苗股份有限公司第二次有擔保轉換公司債(簡稱：高端疫苗二，代碼：65472)發行公司行使債券贖回權暨訂於115年11月09日終止櫃檯買賣等相關事宜。","clause":"第53款","fact_date":"2026-09-17","cite_as":"公開資訊觀測站重大訊息：高端疫苗（6547），2026-09-17 17:53，「公告高端疫苗股份有限公司第二次有擔保轉換公司債(簡稱：高端疫苗二，代碼：65472)發行公司行使債券贖回權暨訂於115年」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2026-09-17-1739-1k2eyhy","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2026-09-17","time":"17:39:26","subject":"公告本公司董事會決議辦理減資彌補虧損召開重大訊息記者會內容","clause":"第44款","fact_date":"2026-09-17","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2026-09-17 17:39，「公告本公司董事會決議辦理減資彌補虧損召開重大訊息記者會內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2026-09-17-1618-zlbezl","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2026-09-17","time":"16:18:51","subject":"[補充公告]代重要子公司富康公告董事會通過召開股東會","clause":"第17款","fact_date":"2026-05-25","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2026-09-17 16:18，「[補充公告]代重要子公司富康公告董事會通過召開股東會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2026-09-17-1618-1pjpo8p","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2026-09-17","time":"16:18:32","subject":"[補充公告]代重要子公司富康公告股臨會改選董事長事宜","clause":"第6款","fact_date":"2025-08-29","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2026-09-17 16:18，「[補充公告]代重要子公司富康公告股臨會改選董事長事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2026-09-17-1618-1fkvqn","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2026-09-17","time":"16:18:11","subject":"[補充公告]代重要子公司富康公告董事會通過召開股東臨時會","clause":"第17款","fact_date":"2025-08-15","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2026-09-17 16:18，「[補充公告]代重要子公司富康公告董事會通過召開股東臨時會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2026-09-17-1611-1m4hlde","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2026-09-17","time":"16:11:07","subject":"本公司董事會決議辦理減資彌補虧損","clause":"第9款","fact_date":"2026-09-17","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2026-09-17 16:11，「本公司董事會決議辦理減資彌補虧損」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2026-09-17-1600-1yv5kc4","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2026-09-17","time":"16:00:50","subject":"公告本公司董事會決議召開115年第二次股東臨時會","clause":"第32款","fact_date":"2026-09-17","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2026-09-17 16:00，「公告本公司董事會決議召開115年第二次股東臨時會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2026-09-17-1557-1jvzj7g","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2026-09-17","time":"15:57:38","subject":"代重要子公司富康公告董事會通過發行員工認股權","clause":"第11款","fact_date":"2026-09-17","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2026-09-17 15:57，「代重要子公司富康公告董事會通過發行員工認股權」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4163-2026-09-17-1554-rxx7eg","company_id":"4163","company":"鐿鈦","market":"上櫃","industry":"生技醫療","date":"2026-09-17","time":"15:54:19","subject":"公告本公司註銷收回限制員工權利新股辦理變更登記完成","clause":"第36款","fact_date":"2026-09-17","cite_as":"公開資訊觀測站重大訊息：鐿鈦（4163），2026-09-17 15:54，「公告本公司註銷收回限制員工權利新股辦理變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7607-2026-09-17-1539-90ymwn","company_id":"7607","company":"通用幹細胞*","market":"興櫃","industry":"生技醫療","date":"2026-09-17","time":"15:39:39","subject":"公告本公司發言人任命案。","clause":"第11款","fact_date":"2026-09-17","cite_as":"公開資訊觀測站重大訊息：通用幹細胞*（7607），2026-09-17 15:39，「公告本公司發言人任命案。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2026-09-17-1459-f3ubxp","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2026-09-17","time":"14:59:38","subject":"公告本公司收到「NALTREXONE INJECTABLE SUSTAINEDRELEASE FORMULATION」馬來西亞專利核准通知書。","clause":"第53款","fact_date":"2026-09-17","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2026-09-17 14:59，「公告本公司收到「NALTREXONE INJECTABLE SUSTAINEDRELEASE FORMULATION」馬」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}